Globus Medical (GMED) Cash from Investing Activities (2011 - 2026)

Globus Medical's Cash from Investing Activities history runs 16 years deep, the most recent figure standing at -$182.7 million for Q1 2026.

• Quarterly Cash from Investing Activities fell 239.04% year-over-year to -$182.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$669.1 million (down 34983.89% YoY) and the FY2025 annual result came in at -$355.0 million, down 101.65% from the prior year.
• Cash from Investing Activities was -$182.7 million for Q1 2026 at Globus Medical, down from -$111.4 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $320.6 million in Q4 2023 and bottomed at -$299.1 million in Q2 2025.
• A 5-year average of -$30.7 million and a median of -$46.6 million in 2024 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities surged 19069.23% — and 2025, when it slumped 2782.14%.
• Globus Medical's Cash from Investing Activities stood at -$60.5 million in 2022, then jumped by 630.08% to $320.6 million in 2023, then plunged by 132.48% to -$104.1 million in 2024, then slipped by 7.04% to -$111.4 million in 2025, then plunged by 63.91% to -$182.7 million in 2026.
• Business Quant data shows GMED's Cash from Investing Activities at -$182.7 million in Q1 2026, -$111.4 million in Q4 2025, and -$75.8 million in Q3 2025.